EUVIMEDEUVIMED entdecken
Crossref

Neuroendocrine tumors in patients with inflammatory bowel disease: a case series

Roberta Elisa Rossi, Benedetta Masoni, Giulia Migliorisi, Cristina Bezzio, Alexia Francesca Bertuzzi, Silvia Uccella, Andrea Gerardo Antonio Lania, Alessandro Zerbi, Antonino Spinelli, Cesare Hassan, Alessandro Repici, Alessandro Armuzzi

Endocrine · 2025

DOI: 10.1007/s12020-025-04465-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine, 2025. Verfasst von Roberta Elisa Rossi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, Milan, 20089, Italy. robertaelisa.rossi@gmail.com. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Inflammatory Bowel Diseases, Intestinal Neoplasms, Pancreatic Neoplasms. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The incidence of inflammatory bowel diseases (IBDs) and gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) has increased, but their potential association remains unclear. Chronic inflammation in IBD may contribute to enteroendocrine cell hyperplasia and neoplasia, though evidence for a causal link is limited. This case series describes the characteristics and outcomes of patients with coexisting IBD and GEP-NETs at a tertiary referral center. METHODS: Retrospective case series including all consecutive IBD patients who were referred to the IBD Unit at the IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy, between January 2019 and December 2024 and who had been diagnosed with a GEP-NET. RESULTS: Nine Crohn’s disease patients (44.4% female, mean IBD diagnosis age: 51.1 years) also had GEP-NETs. The median interval between IBD and GEP-NET diagnoses was 39.3 months (0-180). In the totality of six cases that underwent surgical intervention, NETs diagnosis was incidental on the surgical specimen. Lesion sites included ileum (3), appendix (3), stomach (2), and rectum (1). Most NETs were G1 (88.8%); one required somatostatin analogues due to metastases. Treatments included surgery (6), endoscopy (2), and one pending. Over a median 24-month follow-up, no recurrences or disease-related deaths occurred. No cases of ulcerative colitis and concomitant GEP-NET ‘s diagnosis were observed in the patient cohort under consideration. CONCLUSIONS: Patients with Crohn’s disease may have a higher prevalence of GEP-NETs, possibly due to chronic inflammation and immune/microbiota dysregulation. This association does not appear to worsen disease outcomes. Larger studies are needed to explore underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsInflammatory Bowel DiseasesIntestinal NeoplasmsPancreatic NeoplasmsCrohn DiseaseStomach NeoplasmsHumansFemaleMiddle AgedMaleRetrospective StudiesAdultAged

Stichwörter der Autor:innen

Crohn's diseaseGastro-entero-pancreatic neuroendocrine tumorsInflammationInflammatory bowel diseasesOutcomes

Autor:innen und Institutionen

  • Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, Milan, 20089, Italy. robertaelisa.rossi@gmail.com.
  • Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090, Milan, Italy. robertaelisa.rossi@gmail.com.
  • Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, Milan, 20089, Italy.
  • Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090, Milan, Italy.
  • IBD Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, Milan, 20089, Italy.
  • Hematology and Oncology, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, Milan, 20089, Italy.

Zitieren

APA

Rossi, R. E., Masoni, B., Migliorisi, G., Bezzio, C., Bertuzzi, A. F., Uccella, S., Lania, A. G. A., Zerbi, A., Spinelli, A., Hassan, C., Repici, A., & Armuzzi, A. (2025). Neuroendocrine tumors in patients with inflammatory bowel disease: a case series. Endocrine. https://doi.org/10.1007/s12020-025-04465-8

Vancouver

Rossi RE, Masoni B, Migliorisi G, Bezzio C, Bertuzzi AF, Uccella S, et al. Neuroendocrine tumors in patients with inflammatory bowel disease: a case series. Endocrine. 2025. doi:10.1007/s12020-025-04465-8

BibTeX
@article{Rossi2025,
  author = {Rossi, Roberta Elisa and Masoni, Benedetta and Migliorisi, Giulia and Bezzio, Cristina and Bertuzzi, Alexia Francesca and Uccella, Silvia and Lania, Andrea Gerardo Antonio and Zerbi, Alessandro and Spinelli, Antonino and Hassan, Cesare and Repici, Alessandro and Armuzzi, Alessandro},
  title = {Neuroendocrine tumors in patients with inflammatory bowel disease: a case series},
  journal = {Endocrine},
  year = {2025},
  doi = {10.1007/s12020-025-04465-8}
}
Kostenlos starten →